Data on sulforaphane treatment mediated suppression of autoreactive, inflammatory M1 macrophages

Sanjima Pal1, V Badireenath Konkimalla1

  • 1School of Biological Sciences, National Institute of Science Education and Research (NISER), PO Bhimpur-Padanpur, Via-Jatni, Khurda 752050, India.

Data in Brief
|May 26, 2016
PubMed

Insights

Sulforaphane (SFN) effectively suppresses inflammation in a model of autoimmune disease by inhibiting M1 macrophages. This study clarifies SFN

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Chronic inflammatory autoimmune diseases like arthritis involve collagen accumulation and M1 macrophage activation.
  • Sulforaphane (SFN) shows potential in arthritis but its impact on macrophage plasticity is unclear.

Purpose of the Study:

  • To investigate the effects of SFN on macrophage polarity and inflammatory responses.
  • To determine if SFN can inhibit collagen-induced M1 macrophage activation.

Main Methods:

  • Utilized flow cytometry, western blot, and ELISA.
  • Developed an in vitro model using soluble human collagens (I-IV) to induce auto-reactive M1 macrophages.

Main Results:

  • SFN demonstrated inhibition of inflammatory responses in the M1 macrophage model.
  • Data confirmed SFN's role in modulating macrophage behavior.

Conclusions:

  • SFN can suppress inflammatory responses driven by collagen in an M1 macrophage model.
  • SFN represents a potential therapeutic agent for autoimmune inflammatory conditions.

Related Concept Videos